X0306 4 2017-02-22 0 0001645113 Novocure Ltd NVCR 0001654356 Kirson Eilon D. C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Scientific Officer Options to Buy Ordinary Shares 7.15 2017-02-22 4 A 0 273000 0.00 A 2027-02-22 Ordinary Shares 273000 273000 D Restricted Stock Unit 2017-02-22 4 A 0 109200 0.00 A Ordinary Shares 109200 109200 D Options to buy 273,000 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Kirson's continued employment through such dates. Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Kirson's continued employment through such dates. /s/ Todd Longsworth, Attorney in fact for Eilon D. Kirson 2017-02-24